Noel Tata's daughter Maya may exit Tata Digital — parent of BigBasket, Tata Neu, Croma and 1mg — for a role at Trent, where brother Neville already runs Star Bazaar. The shift comes as Tata Digital absorbs ₹24,000 crore in investment, weighs a ₹7,000 crore equity infusion, and halves Tata Neu's workforce.

Outlook Business · 6/2/2026, 9:13:39 AM

Tata Trusts chairman Noel Tata has questioned Tata Sons' proposed ₹7,000 crore equity injection into Tata Digital, flagging aggressive 45% revenue growth assumptions and ₹9,000 crore in projected cumulative losses over three years. He even queried whether the group should continue owning Tata Cliq, as BigBasket's market share has slipped to 7% from 40% in 2021 amid quick-commerce onslaught.

Outlook Business · 6/2/2026, 9:13:39 AM

Noel Tata's daughter Maya is reportedly weighing an exit from Tata Digital, the Rs 24,000 crore super-app arm housing BigBasket, Croma, Tata 1mg and Tata Neu, as the unit undergoes restructuring. She is exploring positions at Trent or Tata Consumer Products.

Business Today · Latest · 6/2/2026, 6:05:08 AM

Board reviewed a ₹7,000 crore equity infusion into Tata Digital despite ₹9,000 crore in projected losses over three years. Noel Tata flagged aggressive 45% growth assumptions as BigBasket's market share collapsed from ~40% in 2021 to ~7%, squeezed by Zepto, Blinkit and Swiggy Instamart in quick commerce.

CNBC-TV18 · Companies · 6/2/2026, 3:09:43 AM

Noel Tata's daughter Maya may leave Tata Digital amid a brutal restructuring that has halved Tata Neu's headcount and accumulated Rs 24,000 crore in losses. A pivot to Trent or Tata Consumer Products signals where the family is placing its retail bets.

Times of India · Business · 6/1/2026, 7:55:41 PM

Tata Sons reviews Tata Digital amid mounting capital-intensive losses. New CEO Sajith Sivanandan is repositioning Tata Neu from a consumer-facing super-app into loyalty and payments connective tissue across BigBasket, 1mg, Croma and Cliq, after BigBasket ceded quick-commerce share to Blinkit, Zepto and Swiggy Instamart.

Financial Express · BrandWagon · 5/31/2026, 8:13:25 PM

Tata 1mg hit EBITDA breakeven across all core verticals in Q4 FY26. Diagnostics crossed Rs 600 Cr ARR with 40% YoY growth across 19 NABL labs in 70 cities. D2C surpassed Rs 200 Cr ARR with 65% specialty pharma growth. Offline footprint at 280 stores, targeting 500+ within 12 months.

YourStory · 5/29/2026, 2:44:04 PM

Tata 1mg hit EBITDA breakeven across ePharmacy, diagnostics and D2C in Q4 FY26. Diagnostics crossed Rs 600 cr ARR (+40% YoY) across 19 NABL labs in 70 cities; D2C surpassed Rs 200 cr ARR with Specialty Pharma up 65%. Retail footprint to nearly double to 500+ stores within 12 months.

YourStory · Capital · 5/29/2026, 2:43:54 PM

Tata 1mg turned EBITDA positive across core businesses in FY26 as diagnostics ARR crossed Rs 600 crore (40% YoY) and ePharmacy hit breakeven. Offline footprint to scale from 280 to 500+ stores within 12 months under an omnichannel push, with D2C at Rs 200 crore ARR and Speciality Pharma growing 65%.

The Hindu BusinessLine · 5/27/2026, 12:12:11 PM

Tata 1mg hit EBITDA breakeven across ePharmacy, diagnostics and D2C in FY26. Diagnostics ARR crossed ₹600 cr (+40% YoY) across 19 NABL labs in 70 cities. Speciality pharma grew 65%, D2C ARR hit ₹200 cr. Offline footprint to scale from 280 to 500+ stores over the next 12 months.

CNBC-TV18 · Companies · 5/27/2026, 11:55:53 AM

Mumbai board meet reviews future of Tata Digital stack — BigBasket, Croma, Tata CLiQ, Tata Neu, 1mg — alongside Air India, with FY26 aggregate losses near Rs 29,000 crore. Rs 24,000 crore already deployed in Tata Digital; Rs 20,000 crore debt repaid against Rs 1.75 lakh crore asset base.

Financial Express · BrandWagon · 5/26/2026, 1:08:02 PM

Tata Sons chairman faces board on May 26 with roadmap for new-economy units after FY26 losses ballooned to Rs 29,000 crore against Rs 5,700 crore projected. Tata Digital (BigBasket, 1mg, Croma, CLiQ, Neu) has absorbed Rs 24,000 crore; Air India alone is bleeding $3bn this year.

Times of India · Business · 5/22/2026, 1:57:41 AM

All India Organisation of Chemists and Druggists led offline pharmacists in a nationwide shutdown seeking withdrawal of GSR 817(E) and GSR 220(E), citing prescription violations and deep discounting by online platforms. The pushback targets a market projected to grow from $3.71B in 2025 to $14.08B by 2034.

Business Today · Latest · 5/20/2026, 5:22:29 PM

AIOCD held a one-day shutdown demanding withdrawal of notifications GSR 817(E) and GSR 220(E), targeting deep-discount drug sales by Tata 1mg, PharmEasy, Apollo Pharmacy, Netmeds, Zepto and Blinkit over unverified prescriptions and channel-conflict concerns.

The Hindu BusinessLine · 5/20/2026, 2:53:30 PM

AIOCD-led nationwide bandh protests 20-50% online discounts, pandemic-era home-delivery exemptions and alleged fake-drug risks from Tata 1mg, PharmEasy, Apollo and Netmeds. Chemists demand rollback of notifications enabling e-pharmacy growth threatening small offline retailers.

Business Today · Latest · 5/20/2026, 2:56:26 AM

The Accel- and General Catalyst-backed startup is running a Zepto-style playbook for blood tests — 60-minute home collection, 6-hour reports — across Bengaluru, Delhi, Hyderabad and Mumbai. Bengaluru alone clocks 300,000 samples a month at 20% Ebitda margins, putting it on a collision course with Dr Lal, Metropolis and Tata 1mg.

Mint · 5/19/2026, 1:20:31 PM

Backed by Accel and General Catalyst, Orange Health Labs is processing 300,000 samples a month in Bengaluru at 20% Ebitda margin, scaling a quick-commerce diagnostics model across Delhi, Hyderabad and Mumbai to challenge incumbents in India's fragmented $15-16 bn market by 2030.

Mint · Companies · 5/19/2026, 1:19:34 PM

AIOCD has called a one-day Bharat Bandh on May 20, pulling 12.4 lakh offline chemists off the counter to protest deep discounting by Tata 1mg, PharmEasy, Apollo Pharmacy and Netmeds, plus regulatory relaxations under G.S.R. 220(E) and 817(E). Semi-urban medicine access at risk.

NDTV Profit · 5/18/2026, 3:56:17 PM

AIOCD, representing 12.4 lakh chemists, calls nationwide pharmacy shutdown on May 20 demanding repeal of rules enabling unregulated online drug sales. Action targets deep discounting by Tata 1mg, PharmEasy, Netmeds, Apollo and quick-commerce players like Zepto. Emergency medicines will remain available.

NDTV Profit · 5/13/2026, 12:30:14 PM